Enzyme (MLN): tokenomics, risks and score
A protocol for running investment vaults on chain, where a manager trades within rules enforced by contracts and investors can verify every position.
What Enzyme is, and what it does
This is a DeFi protocol. It provides a financial service such as trading, lending or derivatives through smart contracts rather than through a company, so there is no account to open and no one to approve you.
What the MLN token itself does: It receives a share of the fees the protocol collects, so holding it is a claim on real revenue.
Where it runs: Ethereum and Polygon. Mechanism: On chain asset management infrastructure. It has been running since 2017, so roughly 9 years.
The facts
- TICKER
- MLN
- SECTOR
- DeFi
- CHAIN
- Ethereum and Polygon
- LAUNCHED
- 2017, so around 9 years of operating history
- MECHANISM
- On chain asset management infrastructure
- MAXIMUM SUPPLY
- No hard cap, with a small annual issuance for development
- VALUE CAPTURE
- Fee share
- UPGRADE CONTROL
- DAO governed
- VESTING
- Complete
- LIQUIDITY BAND
- Micro cap. Thin, often a single venue or pool. Treat the quoted price as indicative only.
How the score breaks down
Each dimension is explained on the directory page, and the reasoning behind it is taught in the Academy research process.
Supply and value capture
High ongoing issuance. New tokens are minted continuously and holders are diluted unless they participate. A share of protocol fees reaches holders directly, which is the strongest form of value capture available.
Changes go through token holder governance, so control is distributed but influenced by whoever holds most. Ownership is moderately concentrated. A handful of large holders could move the market.
Where it is strong and where it is not
- Has operated for around 9 years and through at least one full bear market
- The token captures real protocol revenue rather than relying on speculation alone
- Audited, with published reports
- Fully open source, so the code can be independently reviewed
- High ongoing issuance dilutes holders who do not actively participate
- Thin liquidity. Check order book depth before assuming you can exit
Incident history
No major exploit, collapse or regulatory action on record against this asset.
Our read
The main risk
Small scale, and on chain asset management has consistently failed to achieve expected adoption.
Before you buy anything
Check the contract address against the project's own documentation rather than a search result or a screener link, since impersonation tokens with identical names and logos are listed constantly. Check the order book depth before assuming you can exit at the quoted price. And write down what would make you wrong before you buy, not after. The Academy thesis module covers why that single habit protects more capital than any indicator.